Skip to main content


Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Call For Papers

Cross-Journal Series

New Content Item

Contribution of climate change to the spread of infectious diseases 
This cross-journal collection brings together in one place articles outlining those diseases (and their vectors) that are likely to spread or are already spreading across borders due to the effects of climate change.

Thematic Series

New Content ItemBacteriophage based technologies for veterinary applications

A series focusing phage therapy, antimicrobial phage enzymes, phage vaccines, phage diagnosis tools for veterinary applications are welcome.

Edited by Ana Oliveira and Joana Azeredo

Thematic Series

New Content ItemBacteriophage Ecology and Evolution

A series focusing on phage population and community ecology, phage-host interaction, and integrated genomics and post-genomics approaches in microbial ecology are welcome.

Edited by Hugo Oliveira and Joana Azeredo


  1. Authors: Josefina Garcia, Victoria Espejo, Martha Nelson, Merly Sovero, Manuel V Villaran, Jorge Gomez, Melvin Barrantes, Felix Sanchez, Guillermo Comach, Ana E Arango, Nicolas Aguayo, Ivette L de Rivera, Wilson Chicaiza, Mirna Jimenez, Washington Aleman, Francisco Rodriguez…

    Content type: Research

Sign up to receive article alerts

Virology Journal is published continuously online-only. We encourage you to sign up to receive free email alerts to keep up to date with all of the latest articles by registering here.

SARS-CoV-2 and COVID-19

Find a selection of articles published across Springer Nature, as well as additional commentary and books relevant to SARS-CoV-2 and COVID-19 research.

Read more

Aims and scope

Virology Journal is an open access, peer reviewed journal that considers articles on all aspects of virology, including research on the viruses of animals, plants and microbes. The journal welcomes basic research as well as pre-clinical and clinical studies of novel diagnostic tools, vaccines and anti-viral therapies.

Read more

Journal Sections

Emerging viruses: Tom Geisbert, University of Texas Medical Branch, USA
Hepatitis viruses: Alan McLachlan, University of Illinois at Chicago, USA
Herpes viruses: Blossom Damania, University of North Carolina at Chapel Hill, USA
Influenza viruses: Hualan Chen, Chinese Academy of Agricultural Sciences, China
Negative-strand RNA viruses: Bert Rima, Queen’s University Belfast, UK
Other viruses: Erna Geessien Kroon, Universidade Federal de Minas Gerais, Brazil
Plant viruses: Chikara Masuta, Hokkaido University, Japan
Positive-strand RNA viruses: Alexander A Khromykh, University of Queensland, Australia
Retroviruses: Li Wu, Ohio State University, USA
Veterinary DNA viruses: Klaus Osterrieder, Freie Universität Berlin, Germany
Veterinary RNA viruses: Siba Samal, University of Maryland, USA
Viruses of microbes: Joana Azeredo, University of Minho, Portugal

Latest Tweets

Linfa Wang, Editor-in-Chief

Prof Wang is the director of the Programme in Emerging Infectious Diseases at Duke-NUS Medical School, and an honorary professor at the University of Melbourne and the Chinese Academy of Sciences. He is an international leader in the field of emerging zoonotic viruses and virus-host interaction, specialising in bat-borne viruses. After completing his Bachelor's degree in 1982 at the East China Normal University, he went on to obtain his PhD at the University of California, Davis. In 1990, he joined the CSIRO, Australian Animal Health Laboratory where he played a leading role in identifying bats as the natural host of the Severe Acute Respiratory Syndrome (SARS) virus. 

Prof Wang's work has been recognized internationally through various international awards, numerous invited speeches at major international conferences, many top scientific publications, five patents and many invited book chapters. He holds a number of honorary positions and memberships and has received numerous awards such as the 2014 Eureka Prize for Research in Infectious Diseases. In 2010, Prof Wang was elected as a Fellow of Australian Academy of Technological Sciences and Engineering in recognition of his expertise in new and emerging diseases.


Annual Journal Metrics